Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Thymoma × Everolimus × Thoracic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 17 Lung Neoplasms 12 Small Cell Lung Carcinoma 4 Carcinoma, Renal Cell 4 Triple Negative Breast Neoplasms 2 Neuroendocrine Tumors 2 Neoplasm Metastasis 2 Mesothelioma, Malignant 2 Mesothelioma 2 Thymoma 1 Somatostatinoma 1 Recurrence 1 Pheochromocytoma 1 Ovarian Neoplasms 1 Multiple Myeloma 1 Melanoma 1 Insulinoma 1 Hereditary Sensory and Autonomic Neuropathies 1 Glucagonoma 1 Gastrointestinal Neoplasms 1 Gastrinoma 1 Colorectal Neoplasms 1 Carcinoma, Merkel Cell 1 Carcinoma, Medullary 1 Carcinoma, Large Cell 1 Carcinoma, Islet Cell 1 Breast Neoplasms 1 Brain Neoplasms 1 Adenocarcinoma 1

Interventions

pembrolizumab 6 Radiotherapy 6 Cyclophosphamide 6 Cisplatin 6 Sunitinib 5 Carboplatin 5 Paclitaxel 4 Thymectomy 3 130-nm albumin-bound paclitaxel 3 selinexor 2 lenvatinib 2 Taxes 2 Robotic Surgical Procedures 2 Ramucirumab 2 Prednisone 2 Pemetrexed 2 Octreotide 2 Nivolumab 2 N,1,4,4-tetramethyl-8-((4-(4-methylpiperazin-1-yl)phenyl)amino)-4,5-dihydro-1H-pyrazolo(4,3-h)quinazoline-3-carboxamide 2 Methylprednisolone 2 Imatinib Mesylate 2 Etoposide 2 Erlotinib Hydrochloride 2 Drug Therapy 2 Doxorubicin 2 Chemoradiotherapy 2 Celecoxib 2 zimberelimab 1 vorolanib 1 saracatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02049047 2022-09-10

ONC-2010-001

Istituto Clinico Humanitas

Phase 2 Completed

Thymoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡